Quick Answer
20/20 Biolabs, Inc. reported Operating Income of -$3.33 million for fiscal year 2025.
20/20 Biolabs, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$3.33M | +41.3% |
| 2024 | -$5.68M | — |
- 20/20 Biolabs, Inc. showed an increase of +41.3% in Operating Income compared to the prior fiscal year.
- Over the 2024–2025 period, 20/20 Biolabs, Inc.’s operating income has grown by 41.3% (from -$5.68 million to -$3.33 million).
- The most recent figure is from 20/20 Biolabs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: